Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-237613
Filing Date
2024-10-15
Accepted
2024-10-15 16:30:56
Documents
1
Group Members
ELIZABETH HOGESEVEN ONE EIGHT THREE FOUR IRREVOCABLE TRUSTSINAN KALAYOGLU

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d851731dsc13da.htm SC 13D/A 83463
  Complete submission text file 0001193125-24-237613.txt   85039
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Subject) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89550 | Film No.: 241372231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARTESIAN THERAPEUTICS, INC. 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address
Kalayoglu Murat (Filed by) CIK: 0002000002 (see all company filings)

Type: SC 13D/A